These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 37951194

  • 1. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
    Giri PS, Bharti AH, Kode J, Begum R, Dwivedi M.
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
    [Abstract] [Full Text] [Related]

  • 2. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
    Giri PS, Bharti AH, Begum R, Dwivedi M.
    Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic association of nuclear factor of activated T cells' 3'UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population.
    Giri P, Bhimani R, Patil S, Dwivedi M.
    Gene; 2023 Sep 05; 880():147629. PubMed ID: 37429370
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decreased GZMB, NRP1, ITPR1, and SERPINB9 Transcripts Lead to Reduced Regulatory T Cells Suppressive Capacity in Generalized Vitiligo Patients.
    Giri PS, Bharti AH, Dwivedi M.
    J Immunol Res; 2022 Sep 05; 2022():3426717. PubMed ID: 36157881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo.
    Giri PS, Patel SS, Dwivedi M.
    Hum Immunol; 2024 Jan 05; 85(1):110737. PubMed ID: 38057201
    [Abstract] [Full Text] [Related]

  • 9. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
    Giri PS, Mistry J, Dwivedi M.
    J Immunol Res; 2022 Jan 05; 2022():6952299. PubMed ID: 36164321
    [Abstract] [Full Text] [Related]

  • 10. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
    Giri PS, Patel S, Begum R, Dwivedi M.
    Gene; 2021 Feb 05; 768():145295. PubMed ID: 33181260
    [Abstract] [Full Text] [Related]

  • 11. Implication of regulatory T cells' telomere shortening in pathogenesis of generalized vitiligo.
    Giri P, Thakor F, Dwivedi M.
    Hum Immunol; 2024 Jul 05; 85(4):110812. PubMed ID: 38755031
    [Abstract] [Full Text] [Related]

  • 12. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.
    Lili Y, Yi W, Ji Y, Yue S, Weimin S, Ming L.
    PLoS One; 2012 Jul 05; 7(5):e37513. PubMed ID: 22649532
    [Abstract] [Full Text] [Related]

  • 13. Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.
    Dwivedi M, Laddha NC, Arora P, Marfatia YS, Begum R.
    Pigment Cell Melanoma Res; 2013 Jul 05; 26(4):586-91. PubMed ID: 23574980
    [Abstract] [Full Text] [Related]

  • 14. Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor.
    Zeng YQ, Liu XS, Wu S, Zou C, Xie Q, Xu SM, Jin XW, Li W, Zhou A, Dai Z.
    Am J Transplant; 2015 Jul 05; 15(7):1782-92. PubMed ID: 25808405
    [Abstract] [Full Text] [Related]

  • 15. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.
    Lin F, Luo X, Tsun A, Li Z, Li D, Li B.
    Int Immunopharmacol; 2015 Oct 05; 28(2):859-65. PubMed ID: 25870037
    [Abstract] [Full Text] [Related]

  • 16. Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.
    Li Q, Shakya A, Guo X, Zhang H, Tantin D, Jensen PE, Chen X.
    J Immunol; 2012 May 01; 188(9):4268-77. PubMed ID: 22490438
    [Abstract] [Full Text] [Related]

  • 17. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
    Tembhre MK, Parihar AS, Sharma VK, Sharma A, Chattopadhyay P, Gupta S.
    Br J Dermatol; 2015 Apr 01; 172(4):940-50. PubMed ID: 25376752
    [Abstract] [Full Text] [Related]

  • 18. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
    Egusa H, Doi M, Saeki M, Fukuyasu S, Akashi Y, Yokota Y, Yatani H, Kamisaki Y.
    Bone; 2011 Aug 01; 49(2):264-74. PubMed ID: 21504804
    [Abstract] [Full Text] [Related]

  • 19. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
    Lin M, Zhang BX, Shen N, Dong XJ, Zhang C, Qi XY, Zhu J, Li YZ, Man MQ, Tu CX.
    Eur J Dermatol; 2014 Aug 01; 24(6):676-82. PubMed ID: 25335433
    [Abstract] [Full Text] [Related]

  • 20. T regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative marker.
    Liu J, Lluis A, Illi S, Layland L, Olek S, von Mutius E, Schaub B.
    PLoS One; 2010 Oct 12; 5(10):e13267. PubMed ID: 20967272
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.